MStranslate logo
Log In
Lost your password?
Lost Password
Back to login
Search
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us
Breaking
  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast - Episode Library
  • Patient Community Day at ECTRIMS 2025
  • Multiple Sclerosis in 2025 – Key Developments to Date
  • HOME
  • Research
    • Basic Sciences
      • B Cells
    • Conferences
      • AAN
      • ACTRIMS
      • ECTRIMS
      • MS Virtual
    • COVID-19
    • Epstein-Barr virus
    • Genetics
    • Gut Microbiome
    • Hormones
    • Lifestyle
      • Diet
      • Exercise
      • Jelinek Group
      • Vitamin D
    • Medicinal Cannabis
    • Mental Health
    • Progressive MS
    • Remyelination
    • Stem Cells
    • Symptoms
      • Cognition
      • Fatigue
      • Quality of Life
      • Rehabilitation
  • Treatments
    • Alemtuzumab
    • Daclizumab
    • Dimethyl fumarate
    • Fingolimod
    • Interferon-Beta
    • Laquinimod
    • Natalizumab
    • Ocrelizumab
    • Clinical Trials & Studies
      • MIS416
  • Lifestyle
  • Collaborations
    • Dr Sally Shaw
    • Dr Travis Stiles
    • Employment & MS
    • Kriesel Lab
    • MBC@RMH
      • MSBase@MBC
      • PrevANZ
      • Neuroimaging
      • Basic Sciences
      • Ocular Motor
      • Movement Disorders & Rehabilitation
    • MitoQ
    • Multiple Sclerosis Limited
  • Connect
    • Live Research Q&A
  • About MStranslate
    • THE TEAM
    • THE APPROACH
    • VALUES & STANDARDS
  • Contact Us

Author MStranslate

MStranslate

relationships

Relationships and Multiple Sclerosis

MStranslate
March 20, 2019
Lifestyle, Research
The following article was commissioned by MS Limited and has previously been published in their eNewsletter, Intouch.     As most of us have probably found out at some point in our...
Cocoa

Does a Cocoa a Day Keep MS Fatigue Away?

MStranslate
March 19, 2019
Fatigue, Research, Symptoms, Treatments
1 Comment
Research Summary: A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis Fatigue is one of the most...
Facebook Live

Taking The Opportunity To Talk

MStranslate
February 28, 2019
Community, Genetics, Q&A
Next week, we are holding another one of our Facebook Live Q&A sessions.  For this event, the theme will be genetics in multiple sclerosis.  It will provide us an opportunity to discuss a number of key...
HSCT

HSCT Trial Shows Positive Results for RRMS

MStranslate
February 19, 2019
Research, Stem Cells, Treatments
2 Comments
Research Summary: Effect of Nonmyeloablative Hematopoietic Stem Cell Transplantation vs Continued Disease-Modifying Therapy on Disease Progression in Patients With Relapsing-Remitting Multiple Sclerosis: A...
CORe Unit

MS Treatments Delay Progressive Disease

MStranslate
February 12, 2019
Progressive MS, Research, Treatments
Research Summary: Association of Initial Disease-Modifying With Later Conversion to Secondary Progressive Multiple Sclerosis In mid-January, we had the good fortune of getting to break some major multiple...
mental health

MS: Many Stories – Caring For My Mental Health

MStranslate
January 30, 2019
Community, Mental Health, MS: Many Stories, Symptoms
2 Comments
Recently, Brett has begun interacting with the Multiple Sclerosis thread on Reddit.  During one of these discussions, he started having a conversation with a father about his daughter’s MS journey and, in...
Roland Martin

Enhancing Our Knowledge of B Cells in MS

MStranslate
January 29, 2019
B Cells, Basic Sciences, Research
In October 2018, our co-founder and chief science communicator, Brett Drummond, was lucky enough to get the opportunity to travel to and attend the ECTRIMS Congress in Berlin. Following that fantastic meeting,...
b cells

B Cells & Their Role in Multiple Sclerosis

MStranslate
January 4, 2019
B Cells, Basic Sciences, Research, Understanding Science
1 Comment
B cells…we hear about them all the time in relation to multiple sclerosis, but what actually are they? Having done a poll on our Facebook page earlier in the week, we found that many people aren’t quite...
food allergy

Food Allergies & Increased Disease Activity In MS

MStranslate
January 2, 2019
Basic Sciences, Diet, Lifestyle, Research
Recently, we featured a Facebook post that mentioned the results of two major US studies, including one that looked at the links between multiple sclerosis and food allergies (the other on asthma and MS can be...
asthma

Asthma More Common In People With MS

MStranslate
December 28, 2018
Basic Sciences, Research
1 Comment
Recently, we featured a Facebook post that mentioned the results of two major US studies, one of which looked at the links between multiple sclerosis and asthma.  This generated a huge reaction from our...
  1. 8
  2. 9
  3. 10
  4. 11
  5. 12
  6. 13
  7. 14

Posts

  • FDA Decision On Tolebrutinib
  • Multiple Sclerosis Research In 2026
  • Revisiting ECTRIMS Congress 2025
  • UPDATED: The ECTRIMS Podcast – Episode Library
  • Patient Community Day at ECTRIMS 2025

Google+

Get social

Copyright 2014-2018 MStranslate. All Rights Reserved. Contact Us
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.